Primary Hyperparathyroidism: Symptoms You Might Not Recognize and When to Have Surgery

Research-informed explainer — last updated April 12, 2026

Primary hyperparathyroidism is now diagnosed most often in people who feel completely well — yet the disease can slowly damage bones and kidneys if left unaddressed. Understanding which symptoms to watch for, and when international guidelines recommend surgery, can mean the difference between timely cure and avoidable complications.

This article draws on research by John Bilezikian, MD, Dorothy L. and Daniel H. Silberberg Professor of Medicine at NewYork-Presbyterian/Columbia University Irving Medical Center, whose work leading the Third and Fourth International Workshops on Asymptomatic Primary Hyperparathyroidism (cited more than 1,500 and 1,241 times respectively) has defined the modern management algorithm; Karl Insogna, MD, Ensign Professor Emeritus at Yale New Haven Hospital, whose laboratory work on PTH-related peptide biology shaped understanding of calcium dysregulation; Neil Binkley, MD, Director of the UW Osteoporosis Clinical Research Program at the University of Wisconsin Hospitals and Clinics, whose contributions to the Endocrine Society vitamin D guideline (10,319 citations) clarify a critical confound in diagnosis; Meryl LeBoff, MD, Chief of the Calcium and Bone Section at Brigham and Women's Hospital and Harvard Medical School, whose JAMA study on occult vitamin D deficiency in women with hip fracture (543 citations) underscores the fracture stakes; and Mimi Hu, MD, Professor at MD Anderson Cancer Center, whose Endocrine Society guideline on hypercalcemia of malignancy contextualizes the differential diagnosis every patient hears about.

What is primary hyperparathyroidism?

Primary hyperparathyroidism (PHPT) occurs when one or more parathyroid glands — four tiny glands behind the thyroid — become overactive and secrete too much parathyroid hormone (PTH). PTH pulls calcium from bone, raises blood calcium, and forces the kidneys to excrete more calcium in urine. In about 85% of cases a single benign adenoma is responsible. The condition affects roughly 1 in 500 adults and is the most common cause of high blood calcium discovered on routine lab work.

The symptoms you might not expect

Classic PHPT used to be described with the phrase "bones, stones, groans, and psychic moans" — fractures, kidney stones, abdominal pain, and mental fog. That presentation is now uncommon in countries where blood tests are routine. Today, roughly 80% of newly diagnosed patients are asymptomatic on standard evaluation.

But "asymptomatic" is a relative term. Many patients report fatigue, mild cognitive difficulties, decreased concentration, and low mood that they attributed to aging. Some have subtle muscle weakness or joint aching. Only after parathyroidectomy do they realize how much the disease had been affecting them. In a landmark 10-year prospective study published in the New England Journal of Medicine (826 citations), approximately one quarter of patients managed without surgery showed measurable disease progression — including new kidney stones, worsening bone density, and elevated calcium levels.

Why vitamin D status matters at diagnosis

An important nuance: vitamin D deficiency can mask the severity of PHPT and trigger compensatory PTH rises that overlap with primary disease. The Endocrine Society Clinical Practice Guideline on vitamin D (10,319 citations), to which Dr. Binkley contributed, recommends measuring 25-hydroxyvitamin D in all patients being worked up for PHPT. Deficiency should be corrected gradually under supervision, since repleting vitamin D in PHPT occasionally unmasks more significant hypercalcemia. Dr. LeBoff's JAMA study found that 50% of postmenopausal women admitted with acute hip fracture had occult vitamin D deficiency — a reminder that bone consequences are real and preventable.

When do the guidelines say surgery is warranted?

The international guidelines, most recently updated in 2014 with the Fourth International Workshop summary (1,241 citations), set clear thresholds for recommending parathyroidectomy even in patients without overt symptoms:

• Serum calcium more than 1.0 mg/dL above the upper limit of normal
• Bone mineral density T-score of −2.5 or lower at any site, or prior fragility fracture, or vertebral fracture on imaging
• Estimated GFR below 60 mL/min/1.73m², kidney stones or nephrocalcinosis on imaging, or 24-hour urinary calcium above 400 mg/day
• Age under 50

If none of these criteria are met, observation is a reasonable choice — but it requires annual calcium and creatinine checks and bone density measurement every 1–2 years.

What surgery achieves

Minimally invasive parathyroidectomy, guided by pre-operative localization with sestamibi scan or 4D CT, cures more than 95% of patients with single-gland disease. Intraoperative PTH measurement confirms successful removal. The 10-year prospective study showed that patients who underwent surgery had normalization of biochemical values and significant increases in bone mineral density — gains that patients managed without surgery did not achieve.

Surveillance if you choose to watch and wait

Not every patient needs immediate surgery. But observation is not passive. Guidelines call for:

• Serum calcium and creatinine every year
• Bone density at hip, spine, and forearm every 1–2 years
• Abdominal imaging if kidney stones are suspected
• Re-evaluation of surgical candidacy if any threshold is crossed

Distinguishing PHPT from hypercalcemia of malignancy

When blood calcium is high, one urgent question is whether a cancer is the cause. Dr. Hu's work at MD Anderson — including the Endocrine Society guideline on treatment of hypercalcemia of malignancy (91 citations) — outlines the key distinction: in PHPT, PTH is elevated or inappropriately normal; in cancer-related hypercalcemia, PTH is suppressed while PTH-related peptide (PTHrP) may be elevated. This single lab result usually resolves the differential without biopsy.

Questions to ask your doctor

• My calcium was high on a routine blood test — what additional tests do I need to confirm the diagnosis and rule out other causes?
• Do my bone density or kidney function results meet any of the surgical criteria from the international guidelines?
• If I choose surveillance instead of surgery, exactly what will be monitored and how often?
• Should my vitamin D level be checked and corrected before any treatment decision is made?
• If I do need surgery, what is the cure rate at your center and what technique do you use?
• Are there any medications that can manage my calcium level if I am not a surgical candidate?

The bottom line

Primary hyperparathyroidism is common, usually asymptomatic, and curable with a brief outpatient operation. International guidelines define specific thresholds — calcium level, bone density, kidney function, and age — that should trigger a surgical referral even without classic symptoms. Patients who do not meet those criteria can be safely monitored with annual labs and imaging, with surgery reconsidered if the thresholds are ever crossed.